PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
48.62
ESG score below 80% of ANVS's 62.21. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
63.54
Environmental score exceeding 1.2x ANVS's 47.17. Mohnish Pabrai would examine if this environmental advantage creates sustainable cost advantages.
30.99
Social score below 80% of ANVS's 64.21. Jim Chanos would check for potential social license and litigation risks.
51.34
Governance score below 80% of ANVS's 75.24. Jim Chanos would check for potential agency conflicts and oversight failures.